Literature DB >> 12884258

Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice.

Kouya Yamaki1, Hiroyuki Uchida, Yoshiki Harada, Rie Yanagisawa, Hirohisa Takano, Hideyuki Hayashi, Yoki Mori, Shin Yoshino.   

Abstract

The present study was undertaken to study the effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses. For this study, mice were immunized by s.c. injection of ovalbumin (OVA) emulsified with complete Freund's adjuvant into the base of the tail (day 0). Varying doses of indomethacin were orally administrated daily from days 0 to 20. On day 21, anti-OVA IgG2a and interferon-gamma as an indicator of Th1 responses and anti-OVA IgG1 and interleukin-10 as that of Th2 responses were measured. The results showed that treatment with indomethacin was followed by decreases in OVA-specific IgG and proliferation of spleen cells to the antigen. Indomethacin inhibited both Th1 and Th2 responses, although the nonsteroidal anti-inflammatory drug suppressed the former more effectively than the latter. Administration of indomethacin resulted in suppression of antigen (OVA)-induced arthritis that was associated with inhibition of anti-OVA IgG2a but not IgG1 production. These results suggest that nonsteroidal anti-inflammatory drugs may downregulate Th1 and, to a lesser extent, Th2 immune responses. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884258     DOI: 10.1002/jps.10380

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells.

Authors:  Fumiaki Kojima; Andrey Frolov; Rahul Matnani; Jerold G Woodward; Leslie J Crofford
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

2.  Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.

Authors:  Victoria A Blaho; Matthew W Buczynski; Edward A Dennis; Charles R Brown
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

3.  Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.

Authors:  Tsuguto Toda; Shin Yoshino
Journal:  Int J Immunopathol Pharmacol       Date:  2016-06-24       Impact factor: 3.219

4.  Intratracheal exposure to Fab fragments of an allergen-specific monoclonal antibody regulates asthmatic responses in mice.

Authors:  Shin Yoshino; Nobuaki Mizutani; Daiko Matsuoka; Chutha Sae-Wong
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.